source
- FDA proposes new rare disease framework to accelerate therapy developmentDuring a public hearing, FDA officials outlined a newly proposed rare disease framework aimed at creating a lasting regulatory scheme. The initiative seeks to speed the development of safe and eff…
- Chinese biotech BioGeometry secures over $100 million Series A for AI-driven protein designBioGeometry, a four-year-old biotech startup based in Beijing, announced it has closed a Series A financing round of more than $100 million. The capital will be used to expand its artificial-intel…